ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #7,999Hybrid

International Journal of Immunopathology and Pharmacology

Abbreviation (ISO):INT. J. IMMUNOPATHOL. PHARMACOL
•
Identifier (ISSN):0394-6320(Print)/2058-7384(Online)
•
Publisher:SAGE Publications Inc.
Clarivate IF (2026)
2.8↑ +0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for International Journal of Immunopathology and Pharmacology

WoS Q3
12452.1220182.1820192.2120203.2220213.320223.52023320242.620252.82026
Annual Impact Factor Metric
Current (2026):2.8
Scopus SJR & RankScopus Q2
0.718
#7,999

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
72

72 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
81articles/year
99.02% Gold OA•94.19% Original Research

Aims & Scope

International Journal of Immunopathology and Pharmacology is an Open Access peer-reviewed journal publishing original papers describing research in the fields of immunology, pathology and pharmacology. The intention is that the journal should reflect both the experimental and clinical aspects of immunology as well as advances in the understanding of the pathology and pharmacology of the immune system.

Topics Covered (Recognized by AI)
Medicine98.2%Biology96.7%Internal medicine82.3%Genetics77.5%Immunology70.1%Chemistry67.1%Biochemistry61.6%Pathology50.5%Endocrinology36%Surgery29.8%Psychology27.5%Immune system24.6%Gene23.4%Organic chemistry20.5%Pharmacology20.4%Physics20.4%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q3
Rank121/183
IndexSCIE
JCRSCIE2026

PATHOLOGY

Q2
Rank32/89
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q3
Rank181/356
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q2
Rank71/183
IndexSCIE
JCISCIE2026

PATHOLOGY

Q2
Rank38/89
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q2
Rank117/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.8
Articles / Year21
Total Citations4
2025
IF2.6
Articles / Year56
Total Citations144
2024
IF3
Articles / Year77
Total Citations367
2023
IF3.5
Articles / Year78
Total Citations745
2022
IF3.298
Articles / Year90
Total Citations1,021

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,999Scopus Q2SCImago Profile
Scopus Coverage:1989-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.718

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.86

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,049 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations710
3-Year Documents244
Citable Documents238

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.4%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ2
ImmunologyQ3
Immunology and AllergyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
In warning list
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

International Journal of Immunopathology and Pharmacology (abbr: INT. J. IMMUNOPATHOL. PHARMACOL, ISSN: 0394-6320) is a peer-reviewed international scholarly journal in the field of Medicine, published by SAGE Publications Inc. in Italy since 1988. The periodical holds a Journal Impact Factor (JIF) of 2.80, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.718 (Q2), an H-index of 72.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 81 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,049 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
SAGE Publications Inc.
Publication Language
English
Frequency
Quarterly
Founding Year
1988
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
BIOLIFE SAS, VIA S STEFANO 39 BIS, SILVA MARINA (TE), ITALY, 64029

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: e710449f-c1e7-4a7f-a28e-be9d913f89e5
Database Updated: 2026-10-01